Trials / Unknown
UnknownNCT02270853
SAS in Patients With Bronchial Carcinoma
Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- RWTH Aachen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
Detailed description
Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard screening tool for sleep apnea in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | sleep apnea screening with ApneaLinkTM | ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-10-21
- Last updated
- 2016-02-18
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02270853. Inclusion in this directory is not an endorsement.